Amazon has given back the recovery that last week's note was built around, dropping 4.8% on the week to $234.11 — and the gap between where the stock trades and where the Street thinks it belongs has stretched further still.
The price action is the dominant story this week. The partial recovery to $244.39 documented in the June 22 report has unwound almost entirely. The one-month loss now stands at 12%, meaningfully worse than the -7.7% reading from the prior note. That puts the stock roughly $79 below the analyst consensus target of $313 — a 34% implied upside that would be unusual at any point in the cycle, let alone with Q2 results just five weeks away on July 31. Two previous earnings prints delivered 1-day gains of 3.5% and 2.1% respectively, with 5-day follow-throughs of 4.8% and 5.9% — a consistent post-results pattern of positive momentum, which makes the current pre-results drift notably at odds with recent history.
The lending and options market offers no support for a bearish thesis. Short interest is minimal at 0.87% of free float — essentially unchanged from the 0.87% reading in the prior note — with over 7 billion shares available to borrow against just 92 million out on loan. Cost to borrow has actually eased further to 0.32%, down 7% on the week despite a 47% rise over the past month that still leaves it at a trivially low absolute level. Options positioning is equally relaxed: the put/call ratio of 0.65 is slightly below its 20-day average of 0.67, with a z-score of -0.56. None of these signals point to a market leaning hard against the stock. The ORTEX short score of 29.2 has barely moved over the past two weeks, consistent with this picture. Positioning is unambiguously quiet.
The Street, meanwhile, has held its nerve. Analyst consensus remains overwhelmingly constructive. The most recent meaningful move was Truist raising its target to $320 in late May. Before that, a wave of post-Q1 upgrades — from JPMorgan to $330, TD Cowen to $350, Citigroup to $325 — has not been reversed. Amazon ranks in the 92nd percentile on analyst recommendation divergence across the ORTEX universe, reflecting near-universal bullish conviction. Factor scores are supportive in places: EPS surprise lands in the 87th percentile, 90-day EPS momentum in the 80th, and the short score rank in the 76th. The weak link is forward earnings growth, where the 12-month forward year-on-year increase ranks in just the 18th percentile — the bear case of compressed near-term margins from CapEx and AWS investment spending showing up in the data.
The broader e-commerce peer group offered no obvious safe harbour this week. MELI fell 2.8% on the day and was flat on the week. CPNG dropped 3.8% in Tuesday's session, even as it managed a 2.9% weekly gain. JMIA was the standout laggard, off 6.3% on the week. The pattern across the group suggests sector-level pressure rather than an Amazon-specific story — which may explain why short sellers have not added materially to their positions despite the slide.
With Q2 earnings on July 31 and the institutional holder base still intact — BlackRock, Vanguard, and State Street all added shares in their most recent filings — the July print becomes the clearest near-term reference point for whether the $79 price-to-target gap closes from above or below.
See the live data behind this article on ORTEX.
Open AMZN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
